Table 1.
The 100 most-cited papers in Neuropathic pain field.
| Rank | First author | Paper | Citations WOS | Citations per year | Citations in 2020 |
|---|---|---|---|---|---|
| 1 | Treede, RD | Treede R-D, Jensen T S, Campbell J N, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes [J]. Neurology, 2008, 70: 1630-5. | 1,569 | 120.69 | 106 |
| 2 | Oxman, MN | Oxman M N, Levin M J, Johnson G R, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults [J]. N Engl J Med, 2005, 352: 2271-84. | 1,449 | 90.56 | 59 |
| 3 | Rolke, R | Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values [J]. Pain, 2006, 123: 231-243. | 1,259 | 83.93 | 126 |
| 4 | Finnerup, NB | Finnerup Nanna B, Attal Nadine, Haroutounian Simon, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis [J]. Lancet Neurol, 2015, 14: 162-73. | 1,240 | 206.67 | 235 |
| 5 | Dworkin, RH | Dworkin Robert H, O'Connor Alec B, Backonja Miroslav, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations [J]. Pain, 2007, 132: 237-251. | 1,232 | 88 | 56 |
| 6 | Decosterd, I | Decosterd Isabelle, Woolf Clifford J, Spared nerve injury: an animal model of persistent peripheral neuropathic pain [J]. Pain, 2000, 87: 149-158. | 1,219 | 58.05 | 99 |
| 7 | Coull, JAM | Coull Jeffrey A M, Beggs Simon, Boudreau Dominic, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain [J]. Nature, 2005, 438: 1017-21. | 1,187 | 74.19 | 93 |
| 8 | Bouhassira, D | Bouhassira Didier, Attal Nadine, Alchaar Haiel, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) [J]. Pain, 2005, 114: 29-36. | 1,140 | 71.25 | 111 |
| 9 | Scholz, J | Scholz Joachim, Woolf Clifford J, The neuropathic pain triad: neurons, immune cells and glia [J]. Nat Neurosci, 2007, 10: 1361-8. | 1,087 | 77.64 | 74 |
| 10 | Attal, N | Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision [J]. Eur J Neurol, 2010, 17: 1113-e88. | 997 | 90.64 | 82 |
| 11 | Finnerup, NB | Finnerup N B, Otto M, McQuay H J, et al. Algorithm for neuropathic pain treatment: an evidence based proposal [J]. Pain, 2005, 118: 289-305. | 783 | 48.94 | 13 |
| 12 | Dworkin, RH | Dworkin Robert H, O'Connor Alec B, Audette Joseph, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update [J]. Mayo Clin Proc, 2010, 85: S3-14. | 772 | 70.18 | 52 |
| 13 | Dworkin, RH | Dworkin Robert H, Backonja Miroslav, Rowbotham Michael C, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations [J]. Arch Neurol, 2003, 60: 1524-34. | 753 | 41.83 | 8 |
| 14 | Baron, R | Baron Ralf, Binder Andreas, Wasner Gunnar, Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment [J]. Lancet Neurol, 2010, 9: 807-19. | 746 | 67.82 | 73 |
| 15 | Campbell, JN | Campbell James N, Meyer Richard A, Mechanisms of neuropathic pain [J]. Neuron, 2006, 52: 77-92. | 718 | 47.87 | 61 |
| 16 | Coull, JAM | Coull Jeffrey A M, Boudreau Dominic, Bachand Karine, et al. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain [J]. Nature, 2003, 424: 938-42. | 697 | 38.72 | 38 |
| 17 | Gilron, I | Gilron Ian, Bailey Joan M, Tu Dongsheng, et al. Morphine, gabapentin, or their combination for neuropathic pain [J]. N Engl J Med, 2005, 352: 1324-34. | 664 | 41.5 | 16 |
| 18 | Jin, SX | Jin Shan-Xue, Zhuang Zhi-Ye, Woolf Clifford J, et al. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain [J]. J Neurosci, 2003, 23: 4017-22. | 635 | 35.28 | 30 |
| 19 | Bouhassira, D | Bouhassira Didier, Attal Nadine, Fermanian Jacques, et al. Development and validation of the Neuropathic Pain Symptom Inventory [J]. Pain, 2004, 108: 248-257. | 626 | 36.82 | 62 |
| 20 | Finnerup, NB | Finnerup Nanna Brix, Sindrup Søren Hein, Jensen Troels Staehelin, The evidence for pharmacological treatment of neuropathic pain [J]. Pain, 2010, 150: 573-581. | 614 | 55.82 | 35 |
| 21 | Haanpaa, M | Haanpää Maija, Attal Nadine, Backonja Miroslav, et al. NeuPSIG guidelines on neuropathic pain assessment [J]. Pain, 2011, 152: 14-27. | 587 | 58.7 | 42 |
| 22 | Tsuda, M | Tsuda Makoto, Inoue Kazuhide, Salter Michael W, Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia [J]. Trends Neurosci, 2005, 28: 101-7. | 583 | 36.44 | 16 |
| 23 | Chessell, IP | Chessell Iain P, Hatcher Jonathan P, Bountra Chas, et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain [J]. Pain, 2005, 114: 386-396. | 554 | 34.63 | 24 |
| 24 | Kumar, K | Kumar Krishna, Taylor Rod S, Jacques Line, et al. Spinal cord stimulation vs. conventional medical management for neuropathic pain: a multicentre randomized controlled trial in patients with failed back surgery syndrome [J]. Pain, 2007, 132: 179-88. | 552 | 39.43 | 61 |
| 25 | Zhuang, ZY | Zhuang Zhi-Ye, Gerner Peter, Woolf Clifford J, et al. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model [J]. Pain, 2005, 114: 149-59. | 550 | 50 | 42 |
| 26 | Maier, C | Maier C, Baron R, Tölle T R, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes [J]. Pain, 2010, 150: 439-450. | 550 | 34.38 | 26 |
| 27 | Dworkin, RH | Dworkin R H, Corbin A E, Young J P, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial [J]. Neurology, 2003, 60: 1274-83. | 534 | 28.67 | 13 |
| 28 | Attal, N | Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision [J]. Eur J Neurol, 2010, 17: 1113-e88. | 529 | 35.27 | 10 |
| 29 | Milligan, ED | Milligan Erin D, Twining Carin, Chacur Marucia, et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats [J]. J Neurosci, 2003, 23: 1026-40. | 523 | 29.06 | 11 |
| 30 | Moalem, G | Moalem Gila, Tracey David J, Immune and inflammatory mechanisms in neuropathic pain [J]. Brain Res Rev, 2006, 51: 240-64. | 513 | 34.2 | 36 |
| 31 | Forero, M | Forero Mauricio, Adhikary Sanjib D, Lopez Hector, et al. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain [J]. Reg Anesth Pain Med, 2016, 41: 621-7. | 489 | 97.8 | 171 |
| 32 | Kawasaki, Y | Kawasaki Yasuhiko, Xu Zhen-Zhong, Wang Xiaoying, et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain [J]. Nat Med, 2008, 14: 331-6. | 472 | 36.31 | 51 |
| 33 | Baron, R | Baron Ralf, Mechanisms of disease: neuropathic pain–a clinical perspective [J]. Nat Clin Pract Neurol, 2006, 2: 95-106. | 454 | 30.27 | 21 |
| 34 | van Hecke, O | van Hecke O, Austin Sophie K, Khan Rafi A, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies [J]. Pain, 2014, 155: 654-662. | 451 | 64.43 | 116 |
| 35 | O'Connor, AB | O'Connor Alec B, Dworkin Robert H, Treatment of neuropathic pain: an overview of recent guidelines [J]. Am J Med, 2009, 122: S22-32. | 451 | 37.58 | 11 |
| 36 | Abbadie, C | Abbadie Catherine, Lindia Jill A, Cumiskey Anne Marie, et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 [J]. Proc Natl Acad Sci U S A, 2003, 100: 7947-52. | 438 | 24.33 | 16 |
| 37 | von Hehn, CA | von Hehn Christian A, Baron Ralf, Woolf Clifford J, Deconstructing the neuropathic pain phenotype to reveal neural mechanisms [J]. Neuron, 2012, 73: 638-52. | 437 | 48.56 | 33 |
| 38 | Rice, ASC | Rice A S C, Maton S, Postherpetic Neuralgia Study Group, Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study [J]. Pain, 2001, 94: 215-224. | 424 | 21.2 | 6 |
| 39 | Love, S | Love S, Coakham H B, Trigeminal neuralgia: pathology and pathogenesis [J]. Brain, 2001, 124: 2347-60. | 407 | 20.35 | 31 |
| 40 | Boucher, TJ | Boucher T J, Okuse K, Bennett D L, et al. Potent analgesic effects of GDNF in neuropathic pain states [J]. Science, 2000, 290: 124-7. | 402 | 19.14 | 13 |
| 41 | Colloca, L | Colloca Luana, Ludman Taylor, Bouhassira Didier, et al. Neuropathic pain [J]. Nat Rev Dis Primers, 2017, 3: 17002. | 387 | 96.75 | 171 |
| 42 | Xiao, HS | Xiao Hua-Sheng, Huang Qiu-Hua, Zhang Fang-Xiong, et al. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain [J]. Proc Natl Acad Sci U S A, 2002, 99: 8360-5. | 385 | 25.67 | 18 |
| 43 | Zhuang, ZY | Zhuang Zhi-Ye, Wen Yeong-Ray, Zhang De-Ren, et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance [J]. J Neurosci, 2006, 26: 3551-60. | 385 | 20.26 | 16 |
| 44 | Freynhagen, R | Freynhagen Rainer, Strojek Krzysztof, Griesing Teresa, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens [J]. Pain, 2005, 115: 254-263. | 383 | 23.94 | 10 |
| 45 | Cruccu, G | Cruccu G, Aziz T Z, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain [J]. Eur J Neurol, 2007, 14: 952-70. | 380 | 27.14 | 14 |
| 46 | Peul, WC | Peul Wilco C, van Houwelingen Hans C, van den Hout Wilbert B, et al. Surgery vs. prolonged conservative treatment for sciatica [J]. N Engl J Med, 2007, 356: 2245-56. | 378 | 27 | 33 |
| 47 | Ji, RR | Ji Ru-Rong, Suter Marc R, p38 MAPK, microglial signaling, and neuropathic pain [J]. Mol Pain, 2007, 3: 33. | 373 | 26.64 | 28 |
| 48 | Inoue, M | Inoue Makoto, Rashid Md Harunor, Fujita Ryousuke, et al. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling [J]. Nat Med, 2004, 10: 712-8. | 372 | 21.88 | 23 |
| 49 | Schmader, KE | Schmader Kenneth E, Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy [J]. Clin J Pain, 2002, 18: 350-4. | 371 | 19.53 | 10 |
| 50 | Gao, YJ | Gao Yong-Jing, Ji Ru-Rong, Chemokines, neuronal-glial interactions, and central processing of neuropathic pain [J]. Pharmacol Ther, 2010, 126: 56-68. | 365 | 33.18 | 29 |
| 51 | Raja, SN | Raja S N, Haythornthwaite J A, Pappagallo M, et al. Opioids vs. antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial [J]. Neurology, 2002, 59: 1015-21. | 365 | 19.21 | 9 |
| 52 | Ibrahim, MM | Ibrahim Mohab M, Deng Hongfeng, Zvonok Alexander, et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS [J]. Proc Natl Acad Sci U S A, 2003, 100: 10529-33. | 363 | 25.93 | 4 |
| 53 | Moulin, D | Moulin Dwight, Boulanger Aline, Clark A J, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society [J]. Pain Res Manag, 2014, 19: 328-35. | 363 | 20.17 | 16 |
| 54 | Sabatowski, R | Sabatowski Rainer, Gálvez Rafael, Cherry David A, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial [J]. Pain, 2004, 109: 26-35. | 362 | 21.29 | 9 |
| 55 | Gao, YJ | Gao Yong-Jing, Zhang Ling, Samad Omar Abdel, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain [J]. J Neurosci, 2009, 29: 4096-108. | 361 | 30.08 | 31 |
| 56 | Austin, PJ | Austin Paul J, Moalem-Taylor Gila, The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines [J]. J Neuroimmunol, 2010, 229: 26-50. | 355 | 32.27 | 38 |
| 57 | Watson, CPN | Watson C Peter N, Moulin Dwight, Watt-Watson Judith, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy [J]. Pain, 2003, 105: 71-8. | 343 | 19.06 | 7 |
| 58 | Jarvis, MF | Jarvis Michael F, Burgard Edward C, McGaraughty Steve, et al. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat [J]. Proc Natl Acad Sci U S A, 2002, 99: 17179-84. | 341 | 21.31 | 10 |
| 59 | Raskin, J | Raskin Joel, Pritchett Yili L, Wang Fujun, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain [J]. Pain Med, 2005, 6: 346-56. | 341 | 17.95 | 15 |
| 60 | Kumar, K | Kumar Krishna, Taylor Rod S, Jacques Line, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation [J]. Neurosurgery, 2008, 63: 762-70; discussion 770. | 339 | 26.08 | 32 |
| 61 | Jensen, MP | Jensen Mark P, Chodroff Marci J, Dworkin Robert H, The impact of neuropathic pain on health-related quality of life: review and implications [J]. Neurology, 2007, 68: 1178-82. | 336 | 24 | 25 |
| 62 | Cruccu, G | Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment [J]. Eur J Neurol, 2004, 11: 153-62. | 335 | 23.93 | 16 |
| 63 | Bennett, MI | Bennett Michael I, Attal Nadine, Backonja Miroslav M, et al. Using screening tools to identify neuropathic pain [J]. Pain, 2007, 127: 199-203. | 335 | 19.71 | 2 |
| 64 | Jensen, TS | Jensen Troels S, Baron Ralf, Translation of symptoms and signs into mechanisms in neuropathic pain [J]. Pain, 2003, 102: 1-8. | 334 | 18.56 | 11 |
| 65 | Saarto, T | Saarto T, Wiffen P J, Antidepressants for neuropathic pain [J]. Cochrane Database Syst Rev, 2005, undefined: CD005454. | 330 | 23.57 | 12 |
| 66 | Saarto, T | Saarto T, Wiffen P J, Antidepressants for neuropathic pain [J]. Cochrane Database Syst Rev, 2007, undefined: CD005454. | 330 | 20.63 | 12 |
| 67 | Leung, L | Leung Lawrence, Cahill Catherine M, TNF-alpha and neuropathic pain–a review [J]. J Neuroinflammation, 2010, 7: 27. | 329 | 29.91 | 36 |
| 68 | Lai, J | Lai Josephine, Gold Michael S, Kim Chang Sook, et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8 [J]. Pain, 2002, 95: 143-52. | 327 | 17.21 | 6 |
| 69 | Wernicke, JF | Wernicke J F, Pritchett Y L, D'Souza D N, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain [J]. Neurology, 2006, 67: 1411-20. | 317 | 26.42 | 26 |
| 70 | King, T | King Tamara, Vera-Portocarrero Louis, Gutierrez Tannia, et al. Unmasking the tonic-aversive state in neuropathic pain [J]. Nat Neurosci, 2009, 12: 1364-6. | 317 | 21.13 | 10 |
| 71 | Ulmann, L | Ulmann Lauriane, Hatcher Jon P, Hughes Jane P, et al. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain [J]. J Neurosci, 2008, 28: 11263-8. | 316 | 24.31 | 32 |
| 72 | Rowbotham, MC | Rowbotham Michael C, Twilling Lisa, Davies Pamela S, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain [J]. N Engl J Med, 2003, 348: 1223-32. | 313 | 17.39 | 6 |
| 73 | Kim, HK | Kim Hee Kee, Park Soon Kwon, Zhou Jun-Li, et al. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain [J]. Pain, 2004, 111: 116-24. | 300 | 17.65 | 22 |
| 74 | Clark, AK | Clark Anna K, Yip Ping K, Grist John, et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain [J]. Proc Natl Acad Sci U S A, 2007, 104: 10655-60. | 299 | 23 | 24 |
| 75 | Cruccu, G | Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management [J]. Eur J Neurol, 2008, 15: 1013-28. | 299 | 21.36 | 19 |
| 76 | Finnerup, NB | Finnerup Nanna B, Haroutounian Simon, Kamerman Peter, et al. Neuropathic pain: an updated grading system for research and clinical practice [J]. Pain, 2016, 157: 1599-1606. | 297 | 59.4 | 92 |
| 77 | Dorn, G | Dorn Gabriele, Patel Sadhana, Wotherspoon Glen, et al. siRNA relieves chronic neuropathic pain [J]. Nucleic Acids Res, 2004, 32: e49. | 294 | 17.29 | 1 |
| 78 | Fox, A | Fox A, Kesingland A, Gentry C, et al. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain [J]. Pain, 2001, 92: 91-100. | 290 | 14.5 | 8 |
| 79 | Zhang, J | Zhang Ji, Shi Xiang Qun, Echeverry Stefania, et al. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain [J]. J Neurosci, 2007, 27: 12396-406. | 289 | 20.64 | 16 |
| 80 | Carragee, EJ | Carragee Eugene J, Han Michael Y, Suen Patrick W, et al. Clinical outcomes after lumbar discectomy for sciatica: the effects of fragment type and anular competence [J]. J Bone Joint Surg Am, 2003, 85: 102-8. | 288 | 16 | 30 |
| 81 | Walker, KM | Walker Katharine M, Urban Laszlo, Medhurst Stephen J, et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain [J]. J Pharmacol Exp Ther, 2003, 304: 56-62. | 286 | 15.89 | 5 |
| 82 | Gold, MS | Gold Michael S, Weinreich Daniel, Kim Chang-Sook, et al. Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain [J]. J Neurosci, 2003, 23: 158-66. | 283 | 18.87 | 18 |
| 83 | Honore, P | Honore Prisca, Donnelly-Roberts Diana, Namovic Marian T, et al. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}G-2, 2-dimethylpropyl)-2-(3, 4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat [J]. J Pharmacol Exp Ther, 2006, 319: 1376-85. | 283 | 17.69 | 15 |
| 84 | Sindrup, SH | Sindrup Søren H, Otto Marit, Finnerup Nanna B, et al. Antidepressants in the treatment of neuropathic pain [J]. Basic Clin Pharmacol Toxicol, 2005, 96: 399-409. | 283 | 15.72 | 5 |
| 85 | Luo, ZD | Luo Z D, Calcutt N A, Higuera E S, et al. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin [J]. J Pharmacol Exp Ther, 2002, 303: 1199-205. | 282 | 16.59 | 11 |
| 86 | Verge, GM | Verge Gail M, Milligan Erin D, Maier Steve F, et al. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions [J]. Eur J Neurosci, 2004, 20: 1150-60. | 282 | 14.84 | 11 |
| 87 | Tanga, FY | Tanga F Y, Raghavendra V, DeLeo J A, Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain [J]. Neurochem Int, 2004, 45: 397-407. | 281 | 16.53 | 12 |
| 88 | Sweitzer, S | Sweitzer S, Martin D, DeLeo J A, Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain [J]. Neuroscience, 2001, 103: 529-39. | 279 | 13.95 | 6 |
| 89 | Sung, B | Sung Backil, Lim Grewo, Mao Jianren, Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats [J]. J Neurosci, 2003, 23: 2899-910. | 278 | 25.27 | 11 |
| 90 | Cruccu, G | Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009 [J]. Eur J Neurol, 2010, 17: 1010-8. | 278 | 15.44 | 8 |
| 91 | Bridges, D | Bridges D, Thompson S W, Rice A S, Mechanisms of neuropathic pain [J]. Br J Anaesth, 2001, 87: 12-26. | 272 | 13.6 | 6 |
| 92 | Khedr, EM | Khedr E M, Kotb H, Kamel N F, et al. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain [J]. J Neurol Neurosurg Psychiatry, 2005, 76: 833-8. | 271 | 16.94 | 11 |
| 93 | Proudfoot, CJ | Proudfoot Clare J, Garry Emer M, Cottrell David F, et al. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain [J]. Curr Biol, 2006, 16: 1591-605. | 269 | 17.93 | 13 |
| 94 | Gronseth, G | Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies [J]. Neurology, 2008, 71: 1183-90. | 265 | 20.38 | 24 |
| 95 | Backonja, M | Backonja Miroslav, Glanzman Robert L, Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials [J]. Clin Ther, 2003, 25: 81-104. | 265 | 14.72 | 7 |
| 96 | Eisenberg, E | Eisenberg Elon, McNicol Ewan D, Carr Daniel B, Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials [J]. JAMA, 2005, 293: 3043-52. | 264 | 16.5 | 10 |
| 97 | Guindon, J | Guindon J, Hohmann A G, Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain [J]. Br J Pharmacol, 2008, 153: 319-34. | 263 | 20.23 | 18 |
| 98 | Krause, SJ | Krause Steven J, Backonja Misha-Miroslav, Development of a neuropathic pain questionnaire [J]. Clin J Pain, 2003, 19: 306-14. | 263 | 14.61 | 12 |
| 99 | Gilron, I | Gilron Ian, Bailey Joan M, Tu Dongsheng, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial [J]. Lancet, 2009, 374: 1252-61. | 262 | 21.83 | 11 |
| 100 | Siddall, PJ | Siddall P J, Cousins M J, Otte A, et al. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial [J]. Neurology, 2006, 67: 1792-800. | 262 | 17.47 | 11 |